• 1
    Ballard C, Gray A, Ayre G. Psychotic symptoms, aggression and restlessness in dementia. Rev Neurol 1999; 155: 4452.
  • 2
    Devanand DP, Jacobs DM, Tang MX et al. The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psychiatry 1997; 54: 257263.
  • 3
    Lawlor BA. Behavioral and psychological symptoms in dementia: The role of atypical antipsychotics. J Clin Psychiatry 2004; 65: 510.
  • 4
    Rabins PV, Mace NL, Lucas MJ. The impact of dementia on the family. JAMA 1982; 248: 333335.
  • 5
    Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990; 147: 10491051.
  • 6
    Asada T, Kinoshita T, Kakuma T. Analysis of behavioral disturbances among community-dwelling elderly with Alzheimer's disease. Alzheimer Dis Assoc Dis 2000; 14: 160167.
  • 7
    Herrmann N, Lanctôt KL. Atypical antipsychotics for neuropsychiatric symptoms of dementia: Malignant or maligned? Drug Saf 2006; 29: 833843.
  • 8
    Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294: 19341943.
  • 9
    Wang PS, Schneeweiss S, Avorn J et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005; 353: 23352341.
  • 10
    Torizuka K, Tatsuno I, Yabe T et al. For the improvement of life (QOL) in the aged. Kampo Med 1999; 50: 763793.
  • 11
    Araki G. Effect of Oren-gedoku-to on dementia. Rounenki Chiho 1990; 4: 110117 (in Japanese).
  • 12
    Otomo E, Togi H, Kogure K et al. Nokekkansyougai ni taisuru Tsumura Oren-gedoku-to no rinsyotekiyuyosei. Geriat Med 1991; 29: 121151 (in Japanese).
  • 13
    Nagakawa H, Kogure K. Efficacy of Oren-gedoku-to (TJ-15) in a model of chronic cerebral ischemia. In: HosoyaE, YamamuraY (eds). Recent Advances in the Pharmacology of Kampo (Japanese Herbal) Medicines. Amsterdam: Excepta Medica, 1988; 213218.
  • 14
    Terasawa K, Shimada Y, Kita T. Choto-san in the treatment of vascular dementia: A double-blind, placebo-controlled study. Phytomedicine 1997; 4: 1522.
  • 15
    Yokoyama K, Shimada Y, Hori E et al. Protective effects of Choto-san and hooks and stems of Uncaria sincesis against delayed neuronal death after transient forebrain ischemia in gerbil. Phytomedicine 2004; 11: 478489.
  • 16
    Yokoyama K, Shimada Y, Hori E et al. Effects of Choto-san and hooks and stems of Uncaria sinensis on antioxidant enzyme activities in the gerbil brain after transient forebrain ischemia. J Ethnopharmacol 2004; 95: 335343.
  • 17
    Kanatani H, Kohda H, Yamasaki K et al. The active principles of the branchlet and hook of Uncaria sinensis Oliv. examined with a 5-hydroxytryptamine receptor binding assay. J Pharm Pharmacol 1985; 37: 401404.
  • 18
    Murakami Y, Zhao Q, Harada K, Tohda M, Watanabe H, Matsumoto K. Choto-san, a Kampo formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor. Pharmacol Biochem Behav 2005; 81: 616625.
  • 19
    Inanaga K, Dainoson K, Ninomiya Y et al. Effects of Toki-syakuyaku-san in patients with senile cognitive disorders. Prog Med 1996; 16: 293300 (in Japanese).
  • 20
    Hagino N. Kampo medicine and neuroendocrine: From here to molecular biology. J Trad Med 1996; 13: 105117.
  • 21
    Liao JF, Jan YM, Huang SY, Wang HH, Yu LL, Chen CF. Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs. Proc Natl Sci Council Republic China B 1995; 19: 151158.
  • 22
    Hara K. Clinical study on the effect of Yokukansan and its allied drugs to emoyional disorder of the aged. Kampo Med 1984; 35: 4954 (In Japanese).
  • 23
    Iwasaki K, Kabayashi S, Chimura Y et al. A randomized, double-blind, placabo-controlled clinical trial of the Chinese herbal medicine ‘BaWei Di Huang Wan’ in the treatment of dementia. J Am Geratr Soc 2004; 52: 15181521.
  • 24
    Iwasaki K, Satoh-Nakagawa T, Maruyama M et al. A randomized, observer-blind,controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry 2005; 66: 248252.
  • 25
    Mizukami K, Hatanaka K, Tanaka Y, Asada T. Five cases of Alzheimer's type dementia showing behavioral and psychological symptoms of dementia (BPSD) successfully treated with Yokukansan. Kampo Med 2006; 57: 655660 (in Japanese with an English abstract).
  • 26
    Mizukami K, Asada T, Kinoshita T et al. A randomized crossover study of a traditional Japanese medicine (kampo) “Yokukansan” in the treatment of beharvioral and psychological symptoms of dementia. Int J Neuropsycopharmacal 2008 (in press).
  • 27
    Ueda Y, Komatsu M, Hiramatsu M. Free radical scavenging activity of the Japanese herbal medicine Toki-syakuyaku-san and its effect on superoxide dismutase activity, lipid peroxides, glutamate, and monoamine metabolites in aged rat brain. Neurochem Res 1996; 21: 909914.
  • 28
    Fujiwara H, Iwasaki K, Furukawa K et al. Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's β-amyloid proteins. J Neurosci Res 2006; 84: 427433.